This is in agreement with previous studies that showed a neuroprotective effect of GM-CSF in animal models of Parkinson’s disease [40], Alzheimer’s disease [41], stroke [42], and TBI [43,44]. This evidence concerns the gene CSF2 and Alzheimer disease.